BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17724143)

  • 1. Acquired hematopoietic stem-cell disorders and mammalian size.
    Lopes JV; Pacheco JM; Dingli D
    Blood; 2007 Dec; 110(12):4120-2. PubMed ID: 17724143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allometric scaling of the active hematopoietic stem cell pool across mammals.
    Dingli D; Pacheco JM
    PLoS One; 2006 Dec; 1(1):e2. PubMed ID: 17183646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia: proving ground for cancer stem cells.
    Daley GQ
    Cell; 2004 Oct; 119(3):314-6. PubMed ID: 15507204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
    Mukaida N; Tanabe Y; Baba T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The allometry of chronic myeloid leukemia.
    Pacheco JM; Traulsen A; Dingli D
    J Theor Biol; 2009 Aug; 259(3):635-40. PubMed ID: 19362566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
    Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
    Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
    Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of hematopoietic stem cells from stress-induced exhaustion and aging.
    Singh S; Jakubison B; Keller JR
    Curr Opin Hematol; 2020 Jul; 27(4):225-231. PubMed ID: 32398455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.
    Holyoake TL; Jiang X; Drummond MW; Eaves AC; Eaves CJ
    Leukemia; 2002 Apr; 16(4):549-58. PubMed ID: 11960331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic versus acute myelogenous leukemia: a question of self-renewal.
    Jamieson CH; Weissman IL; Passegué E
    Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fundamental prevalence of chronic myeloid leukemia-generating clonogenic cells in the light of the neutrality theory of evolution.
    Jankovic GM; Pavlovic M; Vukomanovic DJ; Colovic MD; Lazarevic V
    Blood Cells Mol Dis; 2001; 27(5):913-7. PubMed ID: 11783955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive fitness advantage of BCR-ABL expressing leukemia cells.
    Traulsen A; Pacheco JM; Dingli D
    Cancer Lett; 2010 Aug; 294(1):43-8. PubMed ID: 20153920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chronic myeloid leukemia stem cell.
    Nicholson E; Holyoake T
    Clin Lymphoma Myeloma; 2009; 9 Suppl 4():S376-81. PubMed ID: 20007106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cells: cancer involvement and myeloid leukemia.
    Li XL; Xue Y; Yang YJ; Zhang CX; Wang Y; Duan YY; Meng YN; Fu J
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1829-36. PubMed ID: 26044227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells.
    Era T
    Int J Hematol; 2002 Jul; 76(1):35-43. PubMed ID: 12138893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL insufficiency for the transformation of human stem cells into CML.
    Matioli GT
    Med Hypotheses; 2002 Nov; 59(5):588-9. PubMed ID: 12376083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia.
    Lin H; Monaco G; Sun T; Ling X; Stephens C; Xie S; Belmont J; Arlinghaus R
    Oncogene; 2005 May; 24(20):3246-56. PubMed ID: 15735695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia.
    Colijn C; Mackey MC
    J Theor Biol; 2005 Nov; 237(2):117-32. PubMed ID: 15975596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.